JP4126374B2 - Composition for producing biological models such as blood vessel walls and internal organs - Google Patents
Composition for producing biological models such as blood vessel walls and internal organs Download PDFInfo
- Publication number
- JP4126374B2 JP4126374B2 JP2003361753A JP2003361753A JP4126374B2 JP 4126374 B2 JP4126374 B2 JP 4126374B2 JP 2003361753 A JP2003361753 A JP 2003361753A JP 2003361753 A JP2003361753 A JP 2003361753A JP 4126374 B2 JP4126374 B2 JP 4126374B2
- Authority
- JP
- Japan
- Prior art keywords
- component
- composition
- model
- producing
- biological model
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000203 mixture Substances 0.000 title claims description 86
- 210000004204 blood vessel Anatomy 0.000 title claims description 16
- 210000001835 viscera Anatomy 0.000 title claims description 13
- 238000002156 mixing Methods 0.000 claims description 21
- 238000004519 manufacturing process Methods 0.000 claims description 20
- 108010010803 Gelatin Proteins 0.000 claims description 19
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 claims description 19
- 229920000159 gelatin Polymers 0.000 claims description 19
- 239000008273 gelatin Substances 0.000 claims description 19
- 235000019322 gelatine Nutrition 0.000 claims description 19
- 235000011852 gelatine desserts Nutrition 0.000 claims description 19
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 15
- 150000001875 compounds Chemical class 0.000 claims description 15
- 238000001035 drying Methods 0.000 claims description 15
- 239000003086 colorant Substances 0.000 claims description 14
- 235000018185 Betula X alpestris Nutrition 0.000 claims description 13
- 235000018212 Betula X uliginosa Nutrition 0.000 claims description 13
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 13
- 229920001577 copolymer Polymers 0.000 claims description 12
- 239000004925 Acrylic resin Substances 0.000 claims description 11
- 229920000178 Acrylic resin Polymers 0.000 claims description 11
- 229920000642 polymer Polymers 0.000 claims description 11
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 10
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims description 10
- 229920001817 Agar Polymers 0.000 claims description 10
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 10
- 239000008272 agar Substances 0.000 claims description 10
- 239000000178 monomer Substances 0.000 claims description 10
- 238000000465 moulding Methods 0.000 claims description 10
- 229920000936 Agarose Polymers 0.000 claims description 9
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims description 9
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 claims description 9
- 239000011976 maleic acid Substances 0.000 claims description 9
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 claims description 9
- 125000005397 methacrylic acid ester group Chemical group 0.000 claims description 9
- 125000005396 acrylic acid ester group Chemical group 0.000 claims description 8
- 229920001519 homopolymer Polymers 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 230000009278 visceral effect Effects 0.000 claims description 8
- 235000015203 fruit juice Nutrition 0.000 claims description 7
- 235000012907 honey Nutrition 0.000 claims description 7
- 235000008486 nectar Nutrition 0.000 claims description 7
- 235000000346 sugar Nutrition 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 5
- PMVSDNDAUGGCCE-TYYBGVCCSA-L Ferrous fumarate Chemical compound [Fe+2].[O-]C(=O)\C=C\C([O-])=O PMVSDNDAUGGCCE-TYYBGVCCSA-L 0.000 claims description 4
- 150000007513 acids Chemical class 0.000 claims description 4
- 230000002792 vascular Effects 0.000 claims description 2
- 239000000843 powder Substances 0.000 description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 210000003734 kidney Anatomy 0.000 description 12
- 239000007788 liquid Substances 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 241000196324 Embryophyta Species 0.000 description 8
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 8
- DOIRQSBPFJWKBE-UHFFFAOYSA-N dibutyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 description 8
- 239000000839 emulsion Substances 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 7
- 235000013399 edible fruits Nutrition 0.000 description 7
- 239000004816 latex Substances 0.000 description 7
- 229920000126 latex Polymers 0.000 description 7
- 238000001356 surgical procedure Methods 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 6
- 239000001913 cellulose Substances 0.000 description 6
- 229920002678 cellulose Polymers 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 244000274847 Betula papyrifera Species 0.000 description 5
- 235000009113 Betula papyrifera Nutrition 0.000 description 5
- 235000009109 Betula pendula Nutrition 0.000 description 5
- 235000010928 Betula populifolia Nutrition 0.000 description 5
- 235000002992 Betula pubescens Nutrition 0.000 description 5
- 208000033182 PLCG2-associated antibody deficiency and immune dysregulation Diseases 0.000 description 5
- 229920002472 Starch Polymers 0.000 description 5
- 239000003973 paint Substances 0.000 description 5
- 235000019698 starch Nutrition 0.000 description 5
- 239000008107 starch Substances 0.000 description 5
- 235000013305 food Nutrition 0.000 description 4
- 239000001530 fumaric acid Substances 0.000 description 4
- 230000001953 sensory effect Effects 0.000 description 4
- 238000012549 training Methods 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- -1 acrylic ester Chemical class 0.000 description 3
- 210000000845 cartilage Anatomy 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 239000004014 plasticizer Substances 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- JHPBZFOKBAGZBL-UHFFFAOYSA-N (3-hydroxy-2,2,4-trimethylpentyl) 2-methylprop-2-enoate Chemical compound CC(C)C(O)C(C)(C)COC(=O)C(C)=C JHPBZFOKBAGZBL-UHFFFAOYSA-N 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 208000037062 Polyps Diseases 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 238000007720 emulsion polymerization reaction Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 150000002772 monosaccharides Chemical class 0.000 description 2
- 239000003505 polymerization initiator Substances 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 229920002689 polyvinyl acetate Polymers 0.000 description 2
- 239000011118 polyvinyl acetate Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 229920002050 silicone resin Polymers 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 241000208140 Acer Species 0.000 description 1
- 241001133760 Acoelorraphe Species 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- 241001061264 Astragalus Species 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- 240000006432 Carica papaya Species 0.000 description 1
- 235000009467 Carica papaya Nutrition 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 244000241235 Citrullus lanatus Species 0.000 description 1
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 240000000716 Durio zibethinus Species 0.000 description 1
- 235000006025 Durio zibethinus Nutrition 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 244000043261 Hevea brasiliensis Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 241000220225 Malus Species 0.000 description 1
- 235000011430 Malus pumila Nutrition 0.000 description 1
- 235000015103 Malus silvestris Nutrition 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- 239000004640 Melamine resin Substances 0.000 description 1
- 229920000877 Melamine resin Polymers 0.000 description 1
- 240000005561 Musa balbisiana Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- CNCOEDDPFOAUMB-UHFFFAOYSA-N N-Methylolacrylamide Chemical compound OCNC(=O)C=C CNCOEDDPFOAUMB-UHFFFAOYSA-N 0.000 description 1
- 208000006735 Periostitis Diseases 0.000 description 1
- 235000006089 Phaseolus angularis Nutrition 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 240000001987 Pyrus communis Species 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 244000062793 Sorghum vulgare Species 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 235000021536 Sugar beet Nutrition 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 240000007098 Vigna angularis Species 0.000 description 1
- 235000010711 Vigna angularis Nutrition 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 229920006222 acrylic ester polymer Polymers 0.000 description 1
- 238000010427 acrylic painting Methods 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000006533 astragalus Nutrition 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 229920006026 co-polymeric resin Polymers 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229910052602 gypsum Inorganic materials 0.000 description 1
- 239000010440 gypsum Substances 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 210000002850 nasal mucosa Anatomy 0.000 description 1
- 229920003052 natural elastomer Polymers 0.000 description 1
- 229920001194 natural rubber Polymers 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 210000003460 periosteum Anatomy 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 229920005749 polyurethane resin Polymers 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000015541 sensory perception of touch Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Images
Landscapes
- Instructional Devices (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Description
本発明は、医学実習等に用い得る生体モデルおよびその製造法、ならびに該生体モデル製造用組成物に関する。 The present invention relates to a biological model that can be used for medical training and the like, a method for producing the biological model, and a composition for producing the biological model.
従来より、医学教育実習、手術手技訓練等のために生体モデルが用いられていた。従来は、主にシリコーン樹脂製のモデルが用いられていた。また、ポリウレタンを主成分とする人体擬似モデル(特許文献1参照)、ポリウレタンおよびエポキシ樹脂を主成分とする人体部材モデル(特許文献2参照)についての報告もあった。これらの生体モデルは、成型後モデル相互の接着性が悪く、パーツごとにモデルを作製してもそれを組み合わせることは困難であった。また、他の材料との接着も極めて悪く、また成型後の加工も困難であった。また、シリコーン樹脂は高価であり、生体モデルも安価に供給することはできなかった。生体モデルは、メス等で切開するときの柔軟性、弾力等の性質が実際の生体の器官、組織と同じであることが望ましい。従来の生体モデルでは、切開したときの感触は、実際の生体とはかけ離れていた。また、パーツ毎に作製し、他のパーツと接着し組合わせ多彩なモデルを作製できるのが好ましい。特に、手術の際に切開する内臓のモデルは、実際の手術と同様の感触(切りごこち)を付与するために必要であった。 Conventionally, biological models have been used for medical education training, surgical technique training, and the like. Conventionally, models made mainly of silicone resin have been used. In addition, there have been reports on a human body pseudo model (see Patent Document 1) mainly composed of polyurethane and a human body member model (see Patent Document 2) mainly composed of polyurethane and epoxy resin. These biological models have poor adhesion between models after molding, and even if models are produced for each part, it is difficult to combine them. In addition, adhesion with other materials was extremely poor, and processing after molding was difficult. In addition, the silicone resin is expensive, and the biological model cannot be supplied at a low cost. It is desirable that the living body model has the same properties as an actual organ or tissue of the living body in terms of flexibility, elasticity and the like when incising with a scalpel or the like. In the conventional living body model, the feel when incised is far from the actual living body. In addition, it is preferable that a variety of models can be produced by making each part and bonding it to other parts. In particular, a model of an internal organ that is incised at the time of surgery is necessary to give a touch (cutting edge) similar to that of actual surgery.
本発明は、軟性、弾力性が動物の血管壁、内臓等に類似した生体モデルの提供を目的とする。 An object of the present invention is to provide a living body model having flexibility and elasticity similar to those of animal blood vessels, internal organs, and the like.
本発明者等は、軟性(硬さ、柔軟性)、弾力性が動物の血管壁、内臓等に類似した生体モデルの製造について鋭意検討を行い、以下の化合物を混合することにより、任意に成型が可能であり、軟性、弾力性が動物の血管壁、内臓等に類似した生体モデル作製用組成物の作製に成功し、本発明を完成させるに至った。 The inventors of the present invention have made extensive studies on the production of biological models that are similar to animal blood vessel walls and internal organs in terms of softness (hardness, flexibility) and elasticity, and can be arbitrarily molded by mixing the following compounds: Thus, the present inventors have succeeded in producing a composition for producing a living body model having flexibility and elasticity similar to those of animal blood vessels, internal organs, etc., and completed the present invention.
すなわち、本発明は、以下の通りである。
[1] 以下の成分(1)から成分(3)を含む生体モデル作製用組成物、
(1) (a)ビニルアセテートのホモポリマーもしくはその部分加水分解物、またはビニ
ルアセテートとアクリル酸エステル、アクリル酸アミド、アクリル酸、メタクリル酸、メタクリル酸エステル、マレイン酸、マレイン酸無水物、及びフマル酸からなる群より選ばれる一種または二種以上のモノマーとのコポリマーもしくはその部分加水分解物を含むポリマー成分、ならびに(b)樹液、果実液、花蜜、蜂蜜および糖類からなる群より選ばれる
一種または二種以上を含む成分を含む化合物、を含む組成物、
(2)ゼラチン、または寒天もしくはアガロース、ならびに
(3)アクリル樹脂を主成分とする化合物
[2] さらに、着色剤を含む[1]の組成物、
[3] 成分(1)の(b)が白樺樹液である[1]または[2]の組成物、
[4] 成分(1)と成分(2)を容積比3:0.5〜2で混合した混合物20gに、成分(3)が0.1から1g含まれる[1]から[3]のいずれかの組成物、
[5] 生体モデルが、血管壁または内臓である[1]から[4]のいずれかの組成物、
[6] 以下の成分(1)から成分(3)を混合し、成型し乾燥させることを含む生体モデルの作製方法、
(1) (a)ビニルアセテートのホモポリマーもしくはその部分加水分解物、またはビニ
ルアセテートとアクリル酸エステル、アクリル酸アミド、アクリル酸、メタクリル酸、メタクリル酸エステル、マレイン酸、マレイン酸無水物、及びフマル酸からなる群より選ばれる一種または二種以上のモノマーとのコポリマーもしくはその部分加水分解物を含むポリマー成分、ならびに(b)樹液、果実液、花蜜、蜂蜜および糖類からなる群より選ばれる
一種または二種以上を含む成分を含む化合物、を含む組成物、
(2)ゼラチン、または寒天もしくはアガロース、ならびに
(3)アクリル樹脂を主成分とする化合物
[7] さらに、着色剤を混合することを含む[6]の生体モデルの作製方法、
[8] 成分(1)の(b)が白樺樹液である、[6]または[7]の生体モデルの作製方法、
[9] 成分(1)と成分(2)を容積比3:0.5〜2で混合した混合物20gに、成分(3)を0.1から1g混合することを含む、[6]から[8]のいずれかの生体モデルの作製方法、
[10] 生体モデルが、血管壁または内臓である、[6]から[9]のいずれかの生体モデルの作製方法、
[11] [1]から[5]のいずれかの組成物を膜状に成型し、乾燥させることを含む、血管壁生体モデルの作製方法、
[12] [1]から[5]のいずれかの組成物を内臓の型に入れて成型し、乾燥させることを含む、内臓生体モデルの作製方法、
[13] [1]から[5]のいずれかの組成物を成型し、他の生体モデルと組み合わせることを含む、生体モデルの作製方法、ならびに
[14] [7]から[13]のいずれかの方法により作製された生体モデル。
That is, the present invention is as follows.
[1] A composition for producing a biological model comprising the following components (1) to (3):
(1) (a) A homopolymer of vinyl acetate or a partial hydrolyzate thereof, or vinyl acetate and acrylic acid ester, acrylic acid amide, acrylic acid, methacrylic acid, methacrylic acid ester, maleic acid, maleic anhydride, and fumar A polymer component comprising a copolymer of one or more monomers selected from the group consisting of acids or a partial hydrolyzate thereof, and (b) one or a group selected from the group consisting of sap, fruit juice, nectar, honey and sugar A composition comprising a compound comprising a component comprising two or more,
(2) Gelatin, or agar or agarose, and (3) A compound mainly composed of acrylic resin
[2] The composition of [1] further comprising a colorant,
[3] The composition of [1] or [2], wherein component (1) (b) is birch sap,
[4] The composition according to any one of [1] to [3], wherein 20 g of a mixture obtained by mixing component (1) and component (2) at a volume ratio of 3: 0.5 to 2 contains 0.1 to 1 g of component (3) ,
[5] The composition according to any one of [1] to [4], wherein the biological model is a blood vessel wall or a visceral organ,
[6] A method for producing a biological model including mixing, molding and drying the following components (1) to (3):
(1) (a) A homopolymer of vinyl acetate or a partial hydrolyzate thereof, or vinyl acetate and acrylic acid ester, acrylic acid amide, acrylic acid, methacrylic acid, methacrylic acid ester, maleic acid, maleic anhydride, and fumar A polymer component comprising a copolymer of one or more monomers selected from the group consisting of acids or a partial hydrolyzate thereof, and (b) one or a group selected from the group consisting of sap, fruit juice, nectar, honey and sugar A composition comprising a compound comprising a component comprising two or more,
(2) Gelatin, or agar or agarose, and (3) A compound mainly composed of acrylic resin
[7] The method for producing a biological model according to [6], further comprising mixing a colorant,
[8] A method for producing a biological model according to [6] or [7], wherein (b) of component (1) is birch sap,
[9] Any of [6] to [8], comprising mixing 0.1 to 1 g of component (3) with 20 g of a mixture in which component (1) and component (2) are mixed at a volume ratio of 3: 0.5-2. A method for producing such a biological model,
[10] The method for producing a biological model according to any one of [6] to [9], wherein the biological model is a blood vessel wall or a visceral organ.
[11] A method for producing a biological model of a blood vessel wall, comprising molding the composition according to any one of [1] to [5] into a film shape and drying the composition,
[12] A method for producing a visceral living body model, comprising molding the composition according to any one of [1] to [5] into a visceral mold and drying the composition;
[13] A method for producing a biological model, comprising molding the composition according to any one of [1] to [5] and combining it with another biological model, and
[14] A biological model produced by the method according to any one of [7] to [13].
本発明の組成物を用いることにより、色、質感等の外観、軟性、弾力性等の特性が動物の血管壁、内臓等に酷似し、メス等で切ったときの切りごこちが実際の人体によく似た生体モデルを作製することができる。本発明の生体モデルは、医学生の教育、手術手技訓練や、手術リハーサル等に用いることができ、また、医師と患者におけるインフォームドコンセントの際の説明用モデルに用いることができる。さらに、メス、ピンセット、鉗子等の手術器具の開発等にも用いることができる。 By using the composition of the present invention, the appearance such as color and texture, softness, elasticity, and other characteristics are very similar to animal blood vessel walls, internal organs, etc. A similar biological model can be created. The biological model of the present invention can be used for medical student education, surgical technique training, surgical rehearsal, and the like, and can also be used as an explanatory model for informed consent between doctors and patients. Furthermore, it can also be used for the development of surgical instruments such as scalpels, tweezers and forceps.
以下、本発明を詳細に説明する。
本発明の生体モデル作製用組成物は、下記(1)から(3)を含むポリマー組成物である。
Hereinafter, the present invention will be described in detail.
The composition for producing a biological model of the present invention is a polymer composition containing the following (1) to (3).
(1)は成分(a)ビニルアセテートのホモポリマーもしくはその部分加水分解物、また
はビニルアセテートとアクリル酸エステル、アクリル酸アミド、アクリル酸、メタクリル酸、メタクリル酸エステル、マレイン酸、マレイン酸無水物、及びフマル酸からなる群より選ばれる一種または二種以上のモノマーとのコポリマーもしくはその部分加水分解物を含むポリマー成分、ならびに(b)樹液、果実液、花蜜、蜂蜜および糖類からなる群より選
ばれる一種または二種以上を含む成分を含む化合物、を含む組成物である。
(2)ゼラチンまたは寒天もしくはアガロース
(3)アクリル樹脂を主成分とする化合物、
さらに、本発明の組成物は、セルロースを主成分とするセルロース系粉体またはデンプンを主成分とするデンプン系粉体を含んでいてもよい。さらに、染料や顔料等の着色剤を含んでいてもよく、着色剤としては限定されないが、例えば、アクリル絵具が挙げられ、アクリル絵具として、Delta Ceramcoat(登録商標)(Delta Technical Coating, Inc.社
製)が挙げられる。
(1) is component (a) homopolymer of vinyl acetate or a partial hydrolyzate thereof, or vinyl acetate and acrylic acid ester, acrylic acid amide, acrylic acid, methacrylic acid, methacrylic acid ester, maleic acid, maleic anhydride, And a polymer component comprising a copolymer with one or more monomers selected from the group consisting of fumaric acid or a partial hydrolyzate thereof, and (b) selected from the group consisting of sap, fruit juice, nectar, honey and sugars It is a composition containing the compound containing the component containing 1 type, or 2 or more types.
(2) Gelatin or agar or agarose (3) A compound mainly composed of acrylic resin,
Further, the composition of the present invention may contain a cellulose-based powder mainly composed of cellulose or a starch-based powder mainly composed of starch. Further, a coloring agent such as a dye or a pigment may be contained, and the coloring agent is not limited, and examples thereof include acrylic paints. Examples of acrylic paints include Delta Ceramcoat (registered trademark) (Delta Technical Coating, Inc. Manufactured).
これらの成分を混合することにより、良好な組成物を得ることができる。必要ならば、水を添加してもよい。 A good composition can be obtained by mixing these components. If necessary, water may be added.
成分(1)のビニルアセテートのホモポリマーもしくはその部分加水分解物、またはビニルアセテートとアクリル酸エステル、アクリル酸アミド、アクリル酸、メタクリル酸、メタクリル酸エステル、マレイン酸、マレイン酸無水物、及びフマル酸からなる群より選ばれる一種または二種以上のモノマーとのコポリマーもしくはその部分加水分解物を含むポリマー成分はエマルジョンの状態であることが望ましい。この意味で、本発明の成分(1)中の成分(a)は、水性ラテックスエマルジョンである。ここで、ラテックスとはポリ
マーまたはコポリマー分子を含有する水性分散体をいう。
Homopolymer of vinyl acetate of component (1) or a partial hydrolyzate thereof, or vinyl acetate and acrylic acid ester, acrylic acid amide, acrylic acid, methacrylic acid, methacrylic acid ester, maleic acid, maleic anhydride, and fumaric acid The polymer component containing a copolymer with one or two or more monomers selected from the group consisting of or a partial hydrolyzate thereof is preferably in an emulsion state. In this sense, component (a) in component (1) of the present invention is an aqueous latex emulsion. Here, latex refers to an aqueous dispersion containing polymer or copolymer molecules.
ビニルアセテートのホモポリマーもしくはコポリマーを含むエマルジョンは、市販品として入手することができる。例えば手芸店などで販売されている以下の製品群が適用できる。「木工用ボンド(コニシ社製、接着剤)」、「モトポジ (MOD PODGE) (PLAID社製、仕上げ剤)」、「ポレア(PLAID社製、仕上げ剤)」、「シャインフィニッシュ(株式会社ジャ
ンティー製、仕上げ剤)」、「ハルグロス(ハルエンタープライズ社製、仕上げ剤)」、
「クリヤポッジ(アメリカンハンディクラフト社製、仕上げ剤)」、「トップコートグロス(株式会社ジャンティー製仕上げ剤)」、商品名「トランスファーコート(株式会社ジャン
ティー製、転写液)」、「ハルトランスファー(ハルエンクープライス社製、転写液)」
、「サンフィニッシェ((株)サンユー社製、仕上げ剤)」などが挙げられる。従って、本発明の素材にはこれらの市販品の1つまたは複数を含ませることができる。このうちモトポジが好適に用いられ、PLAID社のカタログのITEM#CS11222、CS11221、CS11220、CS11219、CS11218、CS11217、CS11213、CS11211、CS11201、CS11202、CS11203、CS11204、CS11205、CS11207、CS11301、CS11302、CS11303等のモトポジを用い得る。また、米国特許第3616005記載のラテックスエマルジョンも好適に用い得る。
Emulsions containing vinyl acetate homopolymers or copolymers are commercially available. For example, the following product groups sold at handicraft stores can be applied. `` Bond for woodwork (made by Konishi Co., Ltd., adhesive) '', `` Moto Podge (made by PLAID, finishing agent) '', `` Porea (made by PLAID, finishing agent) '', `` Shine finish (Janty Co., Ltd.) Made, finishing agent) "," Halgross (Hull Enterprise, finishing agent) ",
“Clear Poggi (American Handicraft Co., Finishing Agent)”, “Top Coat Gloss (Janty Co., Ltd. Finishing Agent)”, Trade Name “Transfer Coat (Jantee Co., Ltd., Transfer Solution)”, “Hull Transfer ( Halen Couprice, transfer solution)
, “San finishe (manufactured by Sanyu Co., Ltd., finishing agent)” and the like. Accordingly, the material of the present invention can include one or more of these commercially available products. Of these, MOTOPOSY is preferably used, and PLAID catalog ITEM # CS11222, CS11221, CS11220, CS11219, CS11218, CS11217, CS11213, CS11211, CS11201, CS11202, CS11203, CS11204, CS11205, CS11207, CS11301, CS11302, CS11303, etc. The following motoposi may be used. Further, latex emulsions described in US Pat. No. 3,616,005 can also be suitably used.
又、本発明で用いられるビニルアセテートのホモポリマーは、ビニルアセテートモノマーを乳化剤、重合開始剤、触媒、保護安定剤、可塑剤、及び各種添加剤を適宜希釈し、混合して、従来公知の方法で乳化重合させることにより容易に得られる。 The vinyl acetate homopolymer used in the present invention is a conventionally known method in which a vinyl acetate monomer is appropriately diluted with an emulsifier, a polymerization initiator, a catalyst, a protective stabilizer, a plasticizer, and various additives, and mixed. It can be easily obtained by emulsion polymerization.
ビニルアセテートのコポリマーは、ビニルアセテートモノマーと、それと共重合させるモノマー(コモノマー)を混合して、乳化剤、重合開始剤、触媒、保護安定剤、可塑剤、及び各種添加剤を適宜選択し、混合して、従来公知の方法で乳化重合させることにより容易に得られる。この場合、コモノマーとして利用できるものとして、アクリル酸エステル、アクリル酸アミド、アクリル酸、メタクリル酸、メタクリル酸エステル、マレイン酸、マレイン酸無水物、及びフマル酸、から選ばれる一種または二種以上のモノマーが挙げられる。このうち、得られる組成物を任意形状に容易に造形・加工・成型でき、軟性、粘性および弾力性を調節できるという機能の観点から判断して、好ましいコモノマーは、アクリル酸エステル、アクリル酸アミド、アクリル酸、メタクリル酸、メタクリル酸エステル、マレイン酸、マレイン酸無水物及びフマル酸からなる群から選ばれる一種または二種以上のモノマーである。より好ましいコモノマーとしてはアクリル酸エステル、アクリル酸アミド、アクリル酸、メタクリル酸、メタクリル酸エステル、マレイン酸、マレイン酸無水物からなる群から選ばれる一種または二種以上のモノマーが挙げられる。特に好ましいコモノマーとしては、アクリル酸エステル、アクリル酸アミド、アクリル酸、メタクリル酸、メタクリル酸エステルからなる群から選ばれる一種または二種以上のモノマーが挙げられる。 A vinyl acetate copolymer is prepared by mixing a vinyl acetate monomer and a monomer (comonomer) to be copolymerized therewith, selecting an emulsifier, a polymerization initiator, a catalyst, a protective stabilizer, a plasticizer, and various additives as appropriate. Thus, it can be easily obtained by emulsion polymerization by a conventionally known method. In this case, one or more monomers selected from acrylic ester, acrylic amide, acrylic acid, methacrylic acid, methacrylic ester, maleic acid, maleic anhydride, and fumaric acid can be used as a comonomer. Is mentioned. Among these, the preferred comonomer is an acrylate ester, an acrylate amide, judging from the viewpoint of the function that the obtained composition can be easily shaped, processed and molded into an arbitrary shape and the flexibility, viscosity and elasticity can be adjusted. One or more monomers selected from the group consisting of acrylic acid, methacrylic acid, methacrylic acid ester, maleic acid, maleic anhydride and fumaric acid. More preferred comonomers include one or more monomers selected from the group consisting of acrylic acid esters, acrylic acid amides, acrylic acid, methacrylic acid, methacrylic acid esters, maleic acid, and maleic anhydride. Particularly preferred comonomers include one or more monomers selected from the group consisting of acrylic acid esters, acrylic acid amides, acrylic acid, methacrylic acid, and methacrylic acid esters.
また、該成分(a)はそれ自体水分を含んでいてもよく、例えば、不揮発成分を含む、ビ
ニルアセテートを主成分とし、ジブチルフタレート等の可塑剤または安定剤を含有するコ
ポリマーを含む水性ラテックスを例示することができる。このような水性ラテックスとして、不揮発性成分を含み、ビニルアセテートを主成分とし、アクリレートを副成分として含有するコポリマーにさらにジブチルフタレートを混合したものが挙げられる。
In addition, the component (a) may itself contain moisture, for example, an aqueous latex containing a non-volatile component, a vinyl acetate as a main component, and a copolymer containing a plasticizer or stabilizer such as dibutyl phthalate. It can be illustrated. Examples of such an aqueous latex include a non-volatile component, a copolymer containing vinyl acetate as a main component and acrylate as a minor component, and further mixed with dibutyl phthalate.
「樹液」とは、植物体の液体成分をいい、松、白樺、メイプル、砂糖キビ、甜菜の樹液が好ましい。これらの植物体から得られる樹液を単独で用いることもできるし、二種以上を混合したものを用いることもできる。樹液は、植物体表面から自然に流出してくるものを用いることもできるし、植物体から種々の方法で抽出したものを用いることもできる。例えば、白樺等の樹の表面に傷をつけて樹液を漏出させたものを用いることができ、また白樺等の幹に適当な太さのチューブを差込み、植物体内を流れる液体を採集して用いることもできる。また、このようにして得られた樹液を例えばフィルター処理して固形成分等を除去して用いてもよい。樹液の成分の一部が含まれている限り本発明の「樹液」に含まれる。例えば、市販の白樺樹液を用いてもよい。白樺樹液の成分として、果糖、ブドウ糖、アミノ酸、リンゴ酸、多糖類(キレラン)、配糖類(シリンガレジノール)およびその他ミネラル類が例示できる。該樹液の主成分を人工的に混合して作製した人工液体も本発明の「樹液」に含まれる。前記白樺樹液の成分は例示であり、地域、季節等により変化し得る。 “Sap” means a liquid component of a plant body, and sap of pine, white birch, maple, sugar millet, sugar beet is preferable. Sap obtained from these plants can be used alone, or a mixture of two or more can be used. As the sap, one that naturally flows out from the surface of the plant body can be used, and one extracted from the plant body by various methods can also be used. For example, the surface of a tree such as a white birch can be used to leak sap, and a tube of an appropriate thickness is inserted into a trunk such as a white birch, and the liquid flowing through the plant body is collected and used. You can also. Further, the sap thus obtained may be used after, for example, filtering to remove solid components. As long as a part of the components of the sap is included, it is included in the “sap” of the present invention. For example, commercially available birch sap may be used. Examples of the components of birch sap include fructose, glucose, amino acids, malic acid, polysaccharides (Kirelan), saccharides (syringarezinol), and other minerals. An artificial liquid prepared by artificially mixing the main components of the sap is also included in the “sap” of the present invention. The components of the birch sap are exemplary, and may vary depending on the region, season, and the like.
「果実液」とは、植物の果実の液体成分をいい、ブトウ、モモ、柑橘類、リンゴ、バナナ、スイカ、メロン、チェリー、ナシ、パイナップル、ヤシ、パパイヤ、マンゴー、ドリアン等の果実の液体成分を用いることができる。これらの果実の液体成分を単独で用いることもできるし、二種以上を混合したものを用いることもできる。果実液は、前記果実からミキサー処理等により得ることができる。このようにして得られた果実液を例えばフィルター処理して固形成分等を除去して用いてもよい。果実液の成分の一部が含まれている限り本発明の「果実液」に含まれる。 “Fruit” refers to the liquid components of plant fruits, including butter, peach, citrus, apple, banana, watermelon, melon, cherry, pear, pineapple, palm, papaya, mango, and durian. Can be used. The liquid component of these fruits can also be used independently, and what mixed 2 or more types can also be used. The fruit liquid can be obtained from the fruit by a mixer treatment or the like. The fruit liquid thus obtained may be used after, for example, filtering to remove solid components. As long as a part of the components of the fruit juice is contained, it is included in the “fruit juice” of the present invention.
「蜂蜜」とは、ミツバチが植物の花の蜜腺から多糖類である花蜜を胃(蜜嚢)の中に吸い取って、単糖類に分解しながら吐き出して巣房の中に蓄えたものをいう。レンゲ、トチ、アカシアから得られるものを一種または二種以上含むものを用いることができる。 “Honey” means that the bees sucked the nectar, which is a polysaccharide, from the nectar of the flower of the plant into the stomach (honeycomb), spit it while breaking down into monosaccharides, and stored it in the nest . What contains 1 type or 2 or more types obtained from astragalus, tochi, and acacia can be used.
上記の樹液、果実液、蜂蜜は水分を含んでおり(例えば、白樺樹液は約90〜約95%の水分を含んでおり、最終的に本発明の素材組成物に含ませるべき水分含量に応じて、適宜水で希釈することができるし、また濃縮して水分含量を低下させてもよい。 The above sap, fruit liquid, and honey contain water (for example, white birch sap contains about 90 to about 95% water, and finally depends on the water content to be included in the material composition of the present invention. And can be diluted with water as appropriate, or may be concentrated to reduce the water content.
「糖類」とは、単糖、二糖、多糖を含み、例えばキシリトール、ショ糖、果糖、グルコース、キトサン、キチン、マンナン、グアーガムが例示される。これらの糖を単独で用いることもできるし、二種以上を混合したものを用いることもできる。 “Saccharides” include monosaccharides, disaccharides and polysaccharides, and examples thereof include xylitol, sucrose, fructose, glucose, chitosan, chitin, mannan and guar gum. These sugars can be used alone, or a mixture of two or more can be used.
上記の本発明の素材組成物の成分(1)として、例えば国際公開公報WO02/24801号に記載の皮膜形成エマルジョン組成物を用いることができる。この皮膜形成用エマルジョン組成物は、国際公開公報WO02/24801号の記載の成分組成を有し、該公報の記載に従って調製することができる。 As the component (1) of the material composition of the present invention, for example, a film-forming emulsion composition described in International Publication WO02 / 24801 can be used. This film-forming emulsion composition has the component composition described in International Publication No. WO02 / 24801, and can be prepared according to the description in the publication.
ゼラチンは、酸処理ゼラチン、アルカリ処理ゼラチンいずれも用い得る。また、その由来も限定されずウシ、ブタ等の哺乳類、魚いずれを由来とするゼラチンを用いることができる。 As the gelatin, either acid-treated gelatin or alkali-treated gelatin can be used. Further, the origin is not limited, and gelatin derived from any mammals such as cattle and pigs and fish can be used.
寒天は海藻から抽出されたアガロースを主成分とする物質であり、例えばテングサ、オゴノリ、オバクサ、伊谷草等の紅藻から抽出したものを用いればよく、粉末寒天、フレーク寒天、固形寒天等市販のものを用いることができる。また、寒天の主成分であるアガロ
ースを用いてもよい。
Agar is a substance mainly composed of agarose extracted from seaweed. Things can be used. Moreover, you may use agarose which is a main component of agar.
アクリル樹脂は、アクリル酸エステルの重合体、メタクリル酸エステルの重合体、またはそれらの共重合体樹脂をいい、さらに本発明においてはアクリロニトリル、アクリルアミド、N-メチロールアクリルアミド等の共重合体をも含む。また、本発明の組成物の成分(3)はアクリル樹脂を主成分として含む化合物であり、上記アクリル樹脂を重量%で60%以上、好ましくは70%以上、さらに好ましくは80%以上、特に好ましくは90%以上、最も好ましくは95%以上含む化合物である。また、エマルジョンであってもよい。本発明の成分(3)としては例えば、アクリル絵具を用いるアクリル画において、アクリル絵具の特性を補助するために用いるメディウムを用いることができる。該メディウムには、ジェッソ、モデリングペースト、グロスポリマーメディウム、マットメディウム、ジェルメディウム、マットバーニッシュ等があり、いずれも用いることができる。メディウムの例として、CHROMA INC.(米国、LITITA,PA 17543 USA)の「JO SONJA’S(登録商標)STROKE&BLENDING MEDIUM」や「JO SONJA’S(登録商標)MAGIC MIX」等が挙げられる。 The acrylic resin refers to an acrylic ester polymer, a methacrylic ester polymer, or a copolymer resin thereof, and further includes a copolymer such as acrylonitrile, acrylamide, and N-methylolacrylamide in the present invention. In addition, component (3) of the composition of the present invention is a compound containing an acrylic resin as a main component, and the acrylic resin is 60% or more by weight%, preferably 70% or more, more preferably 80% or more, particularly preferably. Is a compound containing 90% or more, most preferably 95% or more. Moreover, an emulsion may be sufficient. As the component (3) of the present invention, for example, in an acrylic painting using an acrylic paint, a medium used to assist the characteristics of the acrylic paint can be used. Examples of the medium include gesso, modeling paste, gloss polymer medium, matte medium, gel medium, and matte burnish, and any of them can be used. Examples of the medium include “JO SONJA ’S (registered trademark) STROKE & BLENDING MEDIUM” and “JO SONJA ’S (registered trademark) MAGIC MIX” of CHROMA INC. (LITITA, PA 17543 USA, USA).
セルロース系粉体は、セルロースを主成分とする粉体であり、木材や植物のセルロースを化学的、機械的に処理して微粉化したものである。限定されないが、市販のセルロース粉体、紙を処理して粉体にしたもの、アズキ皮を乾燥させ処理して粉体にしたもの、ビートパルプを乾燥させ処理して粉体にしたもの、白樺葉を乾燥させ処理して粉体にしたもの、玉ねぎ皮を処理して粉体にしたもの等を用いることができる。また、デンプン系粉体は、デンプンを主成分とする粉体であり、限定されないがコムギ粉、上新粉、コーンスターチ、片栗粉等を用いることができる。 Cellulose-based powder is a powder mainly composed of cellulose, and is obtained by finely pulverizing cellulose of wood or plant by chemical and mechanical treatment. Without limitation, commercially available cellulose powder, processed paper to powder, dried azuki bean skin to powder, beet pulp dried to powder, white birch What dried the leaf and processed it into powder, what processed the onion skin into powder, etc. can be used. The starch-based powder is a powder containing starch as a main component, and is not limited, and wheat flour, upper fresh flour, corn starch, potato starch and the like can be used.
本発明の生体モデル作製用組成物は、限定されないが一定の軟性、弾力性を有している動物の皮膚、軟骨膜、粘膜、骨膜等の生体モデルの作製に用いることができる。それぞれのモデルにより、軟性、弾力性は異なっており、モデルに応じて組成を変えることができる。例えば、粉体を添加することにより軟性は小さくなる。上記粉体のうちセルロース系粉体を添加した場合は、鼻粘膜を除く粘膜モデルを作製することができ、デンプン系粉体を添加した場合は、皮膚モデルを作製することができる。また、実際の生体の色彩を再現するためには、上記成分(1)、(2)および(3)に適宜着色剤を混合すればよい。 The composition for producing a living body model of the present invention can be used for making a living body model such as animal skin, perichondrium, mucous membrane, periosteum or the like, which is not limited, but has certain softness and elasticity. Each model has different flexibility and elasticity, and the composition can be changed according to the model. For example, the softness is reduced by adding powder. When cellulose-based powder is added among the above powders, a mucosal model excluding the nasal mucosa can be produced, and when starch-based powder is added, a skin model can be produced. Moreover, in order to reproduce the color of an actual living body, a colorant may be appropriately mixed with the components (1), (2) and (3).
上記の成分の配合比を変えることにより、任意の軟性、弾力性を有する生体モデルを作製することができ、メス等の手術器具による切りごこち等を調節することができる。 By changing the blending ratio of the above components, a biological model having arbitrary flexibility and elasticity can be produced, and the cutting and the like with a surgical instrument such as a scalpel can be adjusted.
さらに、本発明の組成物は、力学的、電磁気的特性、X線に対する特性を付与するため
の素材を含んでいてもよい。このような素材として、例えば鉛粉体等の金属粉体などが挙げられる。また、香料等を含んでいてもよい。
Furthermore, the composition of the present invention may contain a material for imparting mechanical, electromagnetic properties, and X-ray properties. Examples of such a material include metal powder such as lead powder. Moreover, the fragrance | flavor etc. may be included.
また、複雑な構造を有する生体モデルを作製するに当たり、パーツ毎にモデルを作製し、その後パーツ同士を接着する必要がある。また、作製したパーツを適当な位置に固定する場合等、粘着テープ等の他の素材と接着させる必要があることもある。さらに、人体モデル成形後に加工したり、形状を修正する必要があることもある。本発明の組成物は、適当な軟性および弾力性を有しているためこれらの必要に応えることができる。 Further, when creating a biological model having a complicated structure, it is necessary to create a model for each part and then bond the parts together. Moreover, when fixing the produced part in a suitable position, it may be necessary to adhere | attach with other raw materials, such as an adhesive tape. Furthermore, it may be necessary to process or modify the shape after molding the human body model. The composition of the present invention can meet these needs because it has appropriate softness and elasticity.
2.本発明の組成物の製造法
本発明の組成物は、上記の成分を一定の割合で混合することにより製造することができる。
(1)の成分(a)および(b)を含むポリマー組成物は、(a)および(b)にさらに水を混合して製造することができる。例えば、成分(a)、成分(b)および水の混合比は、作製しようと
する生体モデルにより適宜決定でき、変えることができるが、例えば容積比で1〜4:1:1〜4であり、好ましくは1〜3:1:1〜3、さらに好ましくは2:1:2である。
2. Production method of the composition of the present invention The composition of the present invention can be produced by mixing the above-mentioned components at a certain ratio.
The polymer composition containing the components (a) and (b) of (1) can be produced by further mixing water with (a) and (b). For example, the mixing ratio of the component (a), the component (b), and water can be appropriately determined and changed depending on the biological model to be prepared, and is, for example, 1 to 4: 1: 1 to 4 by volume ratio. , Preferably 1-3: 1: 1-3, more preferably 2: 1: 2.
この際、成分(a)の組成は上記の組成を有するものならばなんでもよいが、例えば、不
揮発成分55%の、ポリビニルアセテートの水性ラテックスおよびジブチルフタレートの重量%が、それぞれ80〜95%および5〜20%、好ましくは85〜95%および5%〜15%、さらに好ましくは90〜95%および5〜10%含む組成物が例示できる。より具体的には、不揮発性分55%のポリビニルアセテートの水性ラテックス92.5重量%とジブチルフタレート7.5
重量%とを含む組成物が例示できる。
At this time, the composition of component (a) is not limited as long as it has the above-mentioned composition. For example, the non-volatile component of 55% by weight of polyvinyl acetate aqueous latex and dibutyl phthalate is 80 to 95% and 5%, respectively. Examples include compositions containing -20%, preferably 85-95% and 5-15%, more preferably 90-95% and 5-10%. More specifically, 92.5% by weight aqueous latex of polyvinyl acetate with 55% non-volatile content and 7.5% dibutyl phthalate
Examples thereof include a composition containing% by weight.
成分(2)のゼラチンは、好ましくは純度70%以上のものを用いる。このようなゼラチンの1から10%の濃度、好ましくは3から7%の濃度(W/V)の溶液を(1)に添加する
。この際の、容積比は、成分(1)が3に対して、ゼラチン溶液が0.5から2、好ましく
は0.75から1.25、特に好ましくは1である。また、寒天は市販の乾燥寒天を水に戻して用いればよい。また、アガロースも市販のものを用いればよい。寒天またはアガロースの混合比はゼラチンと同じでよい。
The component (2) gelatin preferably has a purity of 70% or more. A solution of such gelatin with a concentration of 1 to 10%, preferably 3 to 7% (W / V) is added to (1). The volume ratio at this time is 0.5 to 2, preferably 0.75 to 1.25, particularly preferably 1 for the gelatin solution with respect to component (1) of 3. As agar, commercially available dry agar may be returned to water and used. A commercially available agarose may be used. The mixing ratio of agar or agarose may be the same as that of gelatin.
着色剤を添加する場合は、組成物に所望の着色がなされるように、適当量の着色剤を添加すればよい。例えば、着色剤が市販のアクリル絵具、例えばDelta Ceramcoat(登録商
標)(Delta Technical Coating, Inc.社製)の場合、容積比で、上記の成分(1)、(2
)および(3)の混合物4に対して、0.5から2、好ましくは0.75から1.25、特に好まし
くは1添加する。
When a colorant is added, an appropriate amount of colorant may be added so that the composition can be colored as desired. For example, when the colorant is a commercially available acrylic paint, for example, Delta Ceramcoat (registered trademark) (manufactured by Delta Technical Coating, Inc.), the above components (1), (2
) And (3) to mixture 4, 0.5 to 2, preferably 0.75 to 1.25, particularly preferably 1.
成分(3)のアクリル樹脂を主成分とする化合物は、成分(1)および(2)の混合物あるいは成分(1)、(2)および着色剤の混合物20gに0.1から1g、好ましくは0.25か
ら0.75g、さらに好ましくは0.4から0.6g、特に好ましくは0.5g添加すればよい。
The component (3) based on an acrylic resin is used in an amount of 0.1 to 1 g, preferably 0.25 to 0.75, in 20 g of a mixture of components (1) and (2) or a mixture of components (1), (2) and a colorant. g, more preferably 0.4 to 0.6 g, particularly preferably 0.5 g may be added.
また、粉体を添加する場合、成分(1)、(2)および(3)の混合物、または成分(1)、(2)、(3)および着色剤の混合物10gに粉体を0.1から1g、好ましくは0.25か
ら0.75g、さらに好ましくは0.4から0.6g、特に好ましくは0.5g添加すればよい。
When adding powder, 0.1 to 1 g of powder is added to 10 g of the mixture of components (1), (2) and (3), or the mixture of components (1), (2), (3) and colorant. Preferably, 0.25 to 0.75 g, more preferably 0.4 to 0.6 g, and particularly preferably 0.5 g may be added.
乾燥前および乾燥後の本発明の組成物は、例えば触覚や視覚による官能試験により評価することができる。本明細書において官能試験の結果を官能特性と称する。例えば、数人のパネル(触覚等により評価する人)に本発明の組成物を触らせ、その軟性、弾力性等を一定の基準で(例えば、軟性、弾力性の異なる標準組成物を準備しておき、それとの比較で段階評価をする)判定させ、評価することができる。また、軟性、弾力性等を測定するための専用の測定機器を用いてもよい。 The composition of the present invention before and after drying can be evaluated by, for example, a tactile or visual sensory test. In the present specification, the result of the sensory test is referred to as a sensory characteristic. For example, several panels (people who evaluate by tactile sensation) are touched with the composition of the present invention, and their softness, elasticity, etc. are prepared according to a certain standard (for example, standard compositions having different softness and elasticity are prepared. It is possible to make a judgment by making a step evaluation by comparing with that). In addition, a dedicated measuring instrument for measuring flexibility, elasticity, and the like may be used.
3.生体モデルの製造
本発明の生体モデルは、上記のようにして製造した生体モデル作製用組成物から製造することができる。上記組成物を、適当な大きさの容器に厚さ数mmになるように流し込み乾燥させれば血管壁生体モデルができる。この際、乾燥後の組成物は乾燥前に比べ収縮するため、所望の生体モデルの厚さより大きい厚さになるように、組成物を流し込む必要がある。組成物の成分や水分含量により異なるが、乾燥後に乾燥前の1/3から1/10、典型的に
は1/4から1/7、さらに典型的には1/6に厚さが減じるため、例えば、厚さ1mmの粘膜モデルを作製する場合、組成物を厚さ、2から10mm、好ましくは4から7mm、さらに好ましくは6mmの厚さに流し込んで乾燥させる。作製しようとする血管に応じて厚さを適宜換えれば良い。このようにして膜状に成型された血管壁モデルを円筒状にすることにより血管モデルを作製することができる。
3. Production of biological model The biological model of the present invention can be produced from the composition for producing a biological model produced as described above. A vascular wall living body model can be obtained by pouring the above composition into a container of an appropriate size so as to have a thickness of several mm and drying. At this time, since the composition after drying contracts compared with that before drying, it is necessary to pour the composition so as to have a thickness larger than the thickness of the desired biological model. Depending on the composition and moisture content of the composition, after drying, the thickness is reduced from 1/3 to 1/10, typically from 1/4 to 1/7, more typically to 1/6 before drying. For example, when a mucosal model having a thickness of 1 mm is prepared, the composition is poured into a thickness of 2 to 10 mm, preferably 4 to 7 mm, more preferably 6 mm, and dried. What is necessary is just to change thickness suitably according to the blood vessel to produce. A blood vessel model can be produced by making the blood vessel wall model formed into a film in this way into a cylindrical shape.
また、本発明の組成物を用いて内臓モデルを作製することもできる。内臓は限定されず、脳、心臓、肝臓、膵臓、脾臓、腎臓、膀胱、肺、胃、小腸、大腸、子宮等を作製することができる。内臓により、軟性や弾力性が異なるので、作製しようとする内臓に応じて、適宜上記組成物の各成分の混合比率を変化させればよい。内臓モデルは、石膏等により別途作製した内臓の型に本発明の組成物を流し込んで数時間から数日風乾により乾燥させることにより作製することができる。 Moreover, a visceral model can also be produced using the composition of the present invention. The internal organs are not limited, and the brain, heart, liver, pancreas, spleen, kidney, bladder, lung, stomach, small intestine, large intestine, uterus and the like can be produced. Since the softness and elasticity differ depending on the internal organs, the mixing ratio of each component of the composition may be appropriately changed according to the internal organs to be produced. The visceral model can be produced by pouring the composition of the present invention into a visceral mold separately produced with gypsum or the like and drying it by air drying for several hours to several days.
乾燥後、必要に応じて別途作製した他の筋肉組織、骨組織、軟骨組織等の生体モデルに本発明のモデルを組合わせることにより、実物に近い動物生体モデルを作製することができる。 By combining the model of the present invention with other biological models such as muscular tissue, bone tissue, and cartilage tissue that are separately prepared after drying, an animal biological model close to the real one can be prepared.
さらに、成型した生体モデル表面に実際の生体の画像を印刷してもよい。
さらに、スポンジ状あるいはゲル状材料に乾燥前の液体状態の本発明の組成物を含浸させてもよい。このような方法により、軟骨等の組織、またはポリープ、膿などの疾患部位を再現したモデルを作製することができる。この際、本発明の組成物を含浸させるスポンジ状材料として、限定はされないが、メラミン樹脂性フォーム、天然ゴム製の多孔性パフ等が挙げられる。この場合、上記の成分(1)および(2)を混合し、必要に応じて着色剤および/または粉体を添加してもよい。すなわち、本発明は、成分(1)、成分(2)を含み、必要に応じて着色剤および/または粉体を含む組成物を、スポンジ状材料に含浸させて作製した、軟骨モデルおよびポリープモデルをも包含する。
Furthermore, an image of an actual living body may be printed on the surface of the molded living body model.
Further, a sponge-like or gel-like material may be impregnated with the composition of the present invention in a liquid state before drying. By such a method, a model reproducing a tissue such as cartilage or a diseased site such as polyp or pus can be prepared. At this time, the sponge-like material impregnated with the composition of the present invention is not limited, and examples thereof include a melamine resin foam and a natural rubber porous puff. In this case, the above components (1) and (2) may be mixed, and a colorant and / or powder may be added as necessary. That is, the present invention relates to a cartilage model and a polyp model produced by impregnating a sponge-like material with a composition containing the component (1) and the component (2) and optionally containing a colorant and / or powder. Is also included.
作製した生体モデルは、例えば触覚や視覚による官能試験により評価することができる。実際の生体と軟性、弾力性等の特性を比較することにより評価できる。この際、手術に用い得る生体モデルという観点から、手術に用いる器具を用いる際の取り扱い易さ等を、実際の生体と比較すればよい。手術に用いる器具としては、ピンセット、鉗子(鋭匙鉗子)、截除鉗子等が挙げられ、それぞれ、ピンセットで押し破って穴を空ける際の感触(ピンセット試験)、鉗子で引っ張ったときの感触(鉗子試験)および截除鉗子等のパンチ様の手術器具で穴を切り開けたときの感触(パンチ試験)により評価することができる。 The produced biological model can be evaluated by, for example, a tactile sense or a visual sensory test. It can be evaluated by comparing the actual living body with characteristics such as flexibility and elasticity. At this time, from the viewpoint of a living body model that can be used for surgery, the ease of handling when using an instrument used for surgery may be compared with that of an actual living body. Examples of instruments used for surgery include tweezers, forceps (sharp forceps), scissor forceps, and the like. When touching with tweezers to make a hole (tweezers test), when tweezers are pulled (feeling) It can be evaluated by a touch (punch test) when a hole is cut with a punch-like surgical instrument such as a forceps test and a removal forceps.
さらに、本発明の組成物は、生体由来素材でできた食品等のサンプルモデルに用いることができ、該食品サンプルモデルは、形状だけでなく触感、粘り等も実物の食品に似ている。この際、食品の芳香を呈する香料を本発明の組成物に添加することにより、芳香も実物に似ている食品サンプルモデルを作製することができる。 Furthermore, the composition of the present invention can be used for a sample model such as a food made of a biological material, and the food sample model is similar to a real food not only in shape but also in touch and stickiness. Under the present circumstances, the food sample model which aroma resembles the real thing can be produced by adding the fragrance | flavor which exhibits the aroma of a foodstuff to the composition of this invention.
本発明を以下の実施例によって具体的に説明するが、本発明はこれらの実施例によって限定されるものではない。 The present invention will be specifically described by the following examples, but the present invention is not limited to these examples.
〔実施例1〕 血管モデルの作製
成分(1)を、モトポジ(MOD PODGE GROSS、PLAID社製カタログ番号Item#CS11201)と白樺樹液と水を4:1:2の容積比または2:1:2の容積比で混合して作製した。白樺樹液は、4月の白樺の若葉が芽吹く前に、幹に穴を空けその穴にパイプを取り付けて採取した。
[Example 1] Preparation of blood vessel model Ingredient (1) is mixed with Motoposi (MOD PODGE GROSS, catalog number Item # CS11201 manufactured by PLAID), birch sap and water in a volume ratio of 4: 1: 2 or 2: 1: 2. It was produced by mixing at a volume ratio of The birch sap was collected by making a hole in the trunk and attaching a pipe to the hole before the young birch leaves in April sprouted.
成分(2)としてゼラチン粉末(クックゼラチン(森永製菓株式会社製))2.5gを水
に溶解し、50mlにメスアップしたゼラチン溶液を用いた。また、成分(3)アクリル樹脂を主成分とする化合物としてJO SONJA’S(登録商標) MAGIC MIX (CHROMA INC.製)を用い
た。成分(1)、成分(2)および成分(3)を容積比で3:1:1に混合した。該混合物をコーティングした紙に0.5ml滴下し、膜状に乾燥させた。乾燥させた膜をシリコンワ
ックスを塗布した、直径1mm程度の細い木製の棒に巻き付け、端同士を押し付けることにより接着し、円筒状に成形し、血管モデルを作製した。血管モデルの写真を図1に示す。
As a component (2), a gelatin solution prepared by dissolving 2.5 g of gelatin powder (Cook gelatin (manufactured by Morinaga Seika Co., Ltd.)) in water and making up to 50 ml was used. In addition, JO SONJA'S (registered trademark) MAGIC MIX (manufactured by CHROMA INC.) Was used as the component (3) a compound mainly composed of an acrylic resin. Component (1), component (2) and component (3) were mixed at a volume ratio of 3: 1: 1. 0.5 ml of the mixture was dropped onto the coated paper and dried into a film. The dried film was wrapped around a thin wooden rod with a diameter of about 1 mm coated with silicon wax, and bonded by pressing the ends together to form a cylindrical model. A photograph of the blood vessel model is shown in FIG.
〔実施例2〕 内臓モデルの作製
成分(1)を、モトポジ(MOD PODGE GROSS、PLAID社製カタログ番号Item#CS11201)と白樺樹液と水を4:1:2の容積比または2:1:2の容積比で混合して作製した。白樺樹液は、4月の白樺の若葉が芽吹く前に、幹に穴を空けその穴にパイプを取り付けて採取した。
[Example 2] Preparation of a visceral model Ingredient (1) is a motoposi (MOD PODGE GROSS, catalog number Item # CS11201 manufactured by PLAID), birch sap and water in a volume ratio of 4: 1: 2 or 2: 1: 2. It was produced by mixing at a volume ratio of The birch sap was collected by making a hole in the trunk and attaching a pipe to the hole before the young birch leaves in April sprouted.
成分(2)としてゼラチン粉末(クックゼラチン(森永製菓株式会社製))2.5gを水
に溶解し、50mlにメスアップしたゼラチン溶液を用いた。また、成分(3)アクリル樹脂を主成分とする化合物としてJO SONJA’S(登録商標) MAGIC MIX (CHROMA INC.製)を用い
た。成分(1)、成分(2)および成分(3)を容積比で3:1:1に混合した。
As a component (2), a gelatin solution prepared by dissolving 2.5 g of gelatin powder (Cook gelatin (manufactured by Morinaga Seika Co., Ltd.)) in water and making up to 50 ml was used. In addition, JO SONJA'S (registered trademark) MAGIC MIX (manufactured by CHROMA INC.) Was used as the component (3) a compound mainly composed of an acrylic resin. Component (1), component (2) and component (3) were mixed at a volume ratio of 3: 1: 1.
別途作製しておいた、腎臓の雌型(腎臓の半分ずつ)に上記組成物を流し込み、乾燥させた後、両者を貼り合せた。さらに、該モデルに別途撮影した腎臓の画像を国際公開公報WO02/24801号に記載の皮膜形成エマルジョン組成物をシート状成形したものに転写し、画像を前記腎臓模型に貼りつけて腎臓モデルを作製した。該モデルは、約40℃に加温することにより、柔らかくなり押したときの感触が実際の腎臓と酷似していた。 The composition was poured into a separately produced female kidney (half of each kidney), dried, and then bonded together. Furthermore, the kidney image separately photographed on the model is transferred to a sheet-shaped emulsion-forming emulsion composition described in WO02 / 24801, and the image is pasted on the kidney model to produce a kidney model did. The model was softened by heating to about 40 ° C., and the feeling when pressed was very similar to that of an actual kidney.
図2に本発明の組成物を流し込んだ腎臓の雌型の写真を、図3および4に腎臓モデルの写真を示す。図4は本モデルの柔らかさを示すために、モデルを変形させてある。 FIG. 2 shows a photograph of a female kidney in which the composition of the present invention has been poured, and FIGS. 3 and 4 show photographs of a kidney model. FIG. 4 shows the model deformed to show the softness of the model.
Claims (14)
(1) (a)ビニルアセテートのホモポリマーもしくはその部分加水分解物、またはビニ
ルアセテートとアクリル酸エステル、アクリル酸アミド、アクリル酸、メタクリル酸、メタクリル酸エステル、マレイン酸、マレイン酸無水物、及びフマル酸からなる群より選ばれる一種または二種以上のモノマーとのコポリマーもしくはその部分加水分解物を含むポリマー成分、ならびに(b)樹液、果実液、花蜜、蜂蜜および糖類からなる群より選ばれる
一種または二種以上を含む成分を含む化合物、を含む組成物、
(2)ゼラチン、または寒天もしくはアガロース、ならびに
(3)アクリル樹脂を主成分とする化合物 A composition for preparing a biological model comprising the following components (1) to (3).
(1) (a) A homopolymer of vinyl acetate or a partial hydrolyzate thereof, or vinyl acetate and acrylic acid ester, acrylic acid amide, acrylic acid, methacrylic acid, methacrylic acid ester, maleic acid, maleic anhydride, and fumar A polymer component comprising a copolymer of one or more monomers selected from the group consisting of acids or a partial hydrolyzate thereof, and (b) one or a group selected from the group consisting of sap, fruit juice, nectar, honey and sugar A composition comprising a compound comprising a component comprising two or more,
(2) Gelatin, or agar or agarose, and (3) A compound mainly composed of acrylic resin
(1) (a)ビニルアセテートのホモポリマーもしくはその部分加水分解物、またはビニ
ルアセテートとアクリル酸エステル、アクリル酸アミド、アクリル酸、メタクリル酸、メタクリル酸エステル、マレイン酸、マレイン酸無水物、及びフマル酸からなる群より選ばれる一種または二種以上のモノマーとのコポリマーもしくはその部分加水分解物を含むポリマー成分、ならびに(b)樹液、果実液、花蜜、蜂蜜および糖類からなる群より選ばれる
一種または二種以上を含む成分を含む化合物、を含む組成物、
(2)ゼラチン、または寒天もしくはアガロース、ならびに
(3)アクリル樹脂を主成分とする化合物 A method for producing a living body model, comprising mixing, molding and drying the following components (1) to (3).
(1) (a) A homopolymer of vinyl acetate or a partial hydrolyzate thereof, or vinyl acetate and acrylic acid ester, acrylic acid amide, acrylic acid, methacrylic acid, methacrylic acid ester, maleic acid, maleic anhydride, and fumar A polymer component comprising a copolymer of one or more monomers selected from the group consisting of acids or a partial hydrolyzate thereof, and (b) one or a group selected from the group consisting of sap, fruit juice, nectar, honey and sugar A composition comprising a compound comprising a component comprising two or more,
(2) Gelatin, or agar or agarose, and (3) A compound mainly composed of acrylic resin
。 The method for producing a biological model according to claim 6 or 7, wherein component (1) (b) is birch sap.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003361753A JP4126374B2 (en) | 2003-10-22 | 2003-10-22 | Composition for producing biological models such as blood vessel walls and internal organs |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003361753A JP4126374B2 (en) | 2003-10-22 | 2003-10-22 | Composition for producing biological models such as blood vessel walls and internal organs |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2005128134A JP2005128134A (en) | 2005-05-19 |
JP4126374B2 true JP4126374B2 (en) | 2008-07-30 |
Family
ID=34641602
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003361753A Expired - Lifetime JP4126374B2 (en) | 2003-10-22 | 2003-10-22 | Composition for producing biological models such as blood vessel walls and internal organs |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4126374B2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7771874B2 (en) | 2005-06-29 | 2010-08-10 | Fmc Corporation | Lithium manganese compounds and methods of making the same |
US8021496B2 (en) | 2007-05-16 | 2011-09-20 | Fmc Corporation | Stabilized lithium metal powder for Li-ion application, composition and process |
US8231810B2 (en) | 2004-04-15 | 2012-07-31 | Fmc Corporation | Composite materials of nano-dispersed silicon and tin and methods of making the same |
US11056021B2 (en) | 2015-07-10 | 2021-07-06 | Kotobuki Medical Inc. | Method for producing simulated animal organ and simulated animal organ |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070168066A1 (en) * | 2006-01-18 | 2007-07-19 | Randy-David Burce Grishaber | AAA model for fatigue testing |
JP5176055B2 (en) * | 2007-04-11 | 2013-04-03 | 国立大学法人神戸大学 | Brain model for surgical training |
WO2012001803A1 (en) | 2010-07-01 | 2012-01-05 | 株式会社クロスエフェクト | Method for producing resin molded body of hollow structure body, and core |
JP5763917B2 (en) * | 2010-12-24 | 2015-08-12 | 株式会社Jmc | Artificial organ manufacturing method and artificial organ |
JP2012189909A (en) * | 2011-03-11 | 2012-10-04 | Asahi Intecc Co Ltd | Vascular lesion model |
RU2478234C2 (en) * | 2011-05-24 | 2013-03-27 | Никита Михайлович Мосиенко | Method for levelling optical density of extracted tooth dentin |
JP5773146B2 (en) * | 2011-07-06 | 2015-09-02 | 株式会社ホソダShc | Imitation organ for suturing practice having form and feel of human body organ and method for manufacturing the same |
CN103021246B (en) * | 2012-12-24 | 2015-04-22 | 中国人民解放军第三军医大学 | Production method and application of abdominal organ teaching simulation model applicable to type-B ultrasonic detection |
JP6341562B2 (en) * | 2014-06-02 | 2018-06-13 | 学校法人日本大学 | Chinese medicine abdominal model |
CN111899621B (en) * | 2020-08-22 | 2025-07-15 | 上海萱闱医疗科技有限公司 | Animal heart simulated uterus with a press device and preparation method thereof |
CN115311931A (en) * | 2022-08-26 | 2022-11-08 | 广州医友医学科技发展有限公司 | Simulated bone model for surgical training and forming method thereof |
-
2003
- 2003-10-22 JP JP2003361753A patent/JP4126374B2/en not_active Expired - Lifetime
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8231810B2 (en) | 2004-04-15 | 2012-07-31 | Fmc Corporation | Composite materials of nano-dispersed silicon and tin and methods of making the same |
US8753779B2 (en) | 2004-04-15 | 2014-06-17 | Fmc Corporation | Composite materials of nano-dispersed silicon and tin and methods of making the same |
US7771874B2 (en) | 2005-06-29 | 2010-08-10 | Fmc Corporation | Lithium manganese compounds and methods of making the same |
US8021496B2 (en) | 2007-05-16 | 2011-09-20 | Fmc Corporation | Stabilized lithium metal powder for Li-ion application, composition and process |
US8377236B2 (en) | 2007-05-16 | 2013-02-19 | Fmc Corporation | Stabilized lithium metal powder for Li-ion application, composition and process |
US11056021B2 (en) | 2015-07-10 | 2021-07-06 | Kotobuki Medical Inc. | Method for producing simulated animal organ and simulated animal organ |
Also Published As
Publication number | Publication date |
---|---|
JP2005128134A (en) | 2005-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4126374B2 (en) | Composition for producing biological models such as blood vessel walls and internal organs | |
Smith | Ethnobotany of the Ojibwe Indians | |
Hunter | An anatomical description of the human gravid uterus, and its contents | |
CN104886038B (en) | The method for making zoological specimens | |
CN106421880B (en) | A kind of squid ink polysaccharide/chitosan hemostatic sponge and its preparation method and application | |
JP4189487B2 (en) | Composition for preparing biological models of skin, mucous membranes, etc. | |
Roberts | XII. Studies on biogenesis | |
Knox | The Anatomist's Instructor, and Museum Companion: being practical directions for the formation and subsequent management of anatomical museums | |
CN107873694A (en) | A kind of novel fish skinned-specimen preparation method | |
CN107197856A (en) | The preparation method of black carp skinned-specimen | |
CN103824499B (en) | A kind of preparation method of adult rabbits sample | |
CN107951906A (en) | A kind of crocodile first glue and preparation method thereof | |
Browne | Artistic and Scientific Taxidermy and Modelling-A Manual of Instruction in the Methods of Preserving and Reproducing the Correct Form of All Natural Objects, Including a Chapter on the Modelling of Foliage | |
Fullaway | Monograph of the Gall-Making Cynipidà (CynipinÃ) of California | |
JP6788932B1 (en) | Artificial organ model, its manufacturing method, and surgical technique training method using the artificial organ model | |
CN103824494B (en) | A kind of preparation method of mature rooster sample | |
CN103824498B (en) | A kind of preparation method of adult duck sample | |
JP7256536B2 (en) | Simulated body for treatment training, evaluation method for simulated body for treatment training, and method for manufacturing simulated body for treatment training | |
Kapp | Centralized vowels in Ālu Kuṟumba | |
JP7506610B2 (en) | The process of entomological taxidermy to strengthen the exoskeleton of beetles for later decorative use and to minimize the fragility of specimens | |
Sylvester | The Taxidermists' Manual-Giving Full Instructions in Mounting and Preserving Birds, Mammals, Insects, Fishes, Reptiles, Skeletons, Eggs, Etc | |
Hanauer | Biology experiments for children | |
Evans | The Mummy Case 1. The Pathological Investigation | |
Vega | Burial | |
CN103814889B (en) | A kind of preparation method of adult public dog sample |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050502 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20080415 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4126374 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
EXPY | Cancellation because of completion of term |